The Associate Director, LC Development will lead the development, optimization, transfer, and lifecycle management of liquid chromatography-based methods supporting biologics programs across clinical and commercial phases. This role will oversee a team responsible for release and stability test method development targeting key quality attributes of therapeutic proteins, including size variants, charge variants, hydrophobic variants, fragmentation, excipient analysis and process additives, using phase‑appropriate (U)HPLC modalities (SEC, IEX, RP-HPLC, HIC, and related). The position will partner closely with Quality Control, Process Development, Manufacturing, Quality Assurance, Clinical Stability, and Analytical Technical Transfer Services (ATTS) to ensure robust method performance, successful transfers/validations, and cGMP readiness. The Associate Director will establish technical strategies, introduce new technologies to enhance throughput and capability, and serve as a key technical lead during audits, investigations, and regulatory interactions.